{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T09:02:32Z","timestamp":1784106152654,"version":"3.55.0"},"reference-count":111,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Ocular graft-versus-host disease (oGVHD) remains one of the most challenging complications of allogeneic hematopoietic stem cell transplantation (HSCT), often leading to severe ocular surface morbidity and irreversible vision loss if not properly managed. Diagnostic uncertainty persists due to variability in clinical presentation and a lack of universally accepted criteria, but the greatest clinical burden lies in establishing effective, durable treatment protocols. Current strategies range from lubricants and topical immunomodulators to advanced surgical interventions; however, outcomes remain inconsistent due to delayed recognition and heterogeneous practices across institutions. At institutions like MD Anderson Cancer Center (MDACC), a structured treatment strategy has been developed that emphasizes early recognition and targeted therapy based on the specific ocular tissues affected. This approach integrates patient-reported outcomes with objective ocular findings and applies stepwise therapeutic escalation aligned with tissue-specific pathology. This review offers a brief overview of the clinical burden and pathophysiology of oGVHD, outlines the key diagnostic challenges, and a more detailed discussion on therapeutic strategies with particular emphasis on the targeted tissue-based approaches.<\/jats:p>","DOI":"10.3390\/jcm15051926","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T15:15:29Z","timestamp":1772550929000},"page":"1926","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Current Diagnosis and Management of Ocular Graft-Versus-Host Disease at a Tertiary Cancer Center"],"prefix":"10.3390","volume":"15","author":[{"given":"Eesa M.","family":"Khattak","sequence":"first","affiliation":[{"name":"School of Medicine, Royal College of Surgeons in Ireland-Bahrain, Muharraq 15503, Bahrain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan A.","family":"Seto","sequence":"additional","affiliation":[{"name":"Richard W. Yee, MD PLLC, Houston, TX 77401, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calvin W.","family":"Wong","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rugveda R.","family":"Patil","sequence":"additional","affiliation":[{"name":"Department of Biology, Texas A and M University, College Station, TX 77843, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2867-6320","authenticated-orcid":false,"given":"Dan S.","family":"Gombos","sequence":"additional","affiliation":[{"name":"Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua L.","family":"Olson","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Limerick, V94 T9PX Limerick, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard W.","family":"Yee","sequence":"additional","affiliation":[{"name":"Richard W. Yee, MD PLLC, Houston, TX 77401, USA"},{"name":"Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.survophthal.2023.02.006","article-title":"Ocular graft-versus-host disease (oGVHD): From A to Z","volume":"68","author":"Soleimani","year":"2023","journal-title":"Surv. Ophthalmol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.beha.2008.02.005","article-title":"GVHD pathophysiology: Is acute different from chronic?","volume":"21","author":"Toubai","year":"2008","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1182\/blood.2021012431","article-title":"Nonclassical manifestations of acute GVHD","volume":"138","author":"Zeiser","year":"2021","journal-title":"Blood"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/S0140-6736(09)60237-3","article-title":"Graft-versus-Host Disease","volume":"373","author":"Ferrara","year":"2009","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1182\/blood-2016-06-686618","article-title":"Chronic graft-versus-host disease: Biological insights from preclinical and clinical studies","volume":"129","author":"MacDonald","year":"2017","journal-title":"Blood"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1182\/blood-2010-08-302109","article-title":"Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria","volume":"117","author":"Flowers","year":"2011","journal-title":"Blood"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1182\/blood.2023022735","article-title":"Chronic graft-versus-host disease: Unresolved complication or ancient history?","volume":"144","author":"Pidala","year":"2024","journal-title":"Blood"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1007\/s10792-021-01811-3","article-title":"Ophthalmologic findings and complications before and after hematopoietic stem cell transplantation: Single-center study","volume":"41","author":"Hakan","year":"2021","journal-title":"Int. Ophthalmol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"6430953","DOI":"10.1155\/2018\/6430953","article-title":"Manifestation of Clinical Categories of Ocular Graft-versus-Host Disease","volume":"2018","author":"Qiu","year":"2018","journal-title":"J. Ophthalmol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1038\/bmt.2015.24","article-title":"A cross-sectional study on vision-related quality of life in patients with ocular GvHD","volume":"50","author":"Pezzotta","year":"2015","journal-title":"Bone Marrow Transplant."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"12985","DOI":"10.1038\/s41598-022-17032-2","article-title":"Long-term clinical outcomes and predictive factors in patients with chronic ocular graft-versus-host disease","volume":"12","author":"Yoon","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1016\/j.bbmt.2018.11.021","article-title":"Ocular Graft-versus-Host Disease after Hematopoietic Cell Transplantation: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation","volume":"25","author":"Inamoto","year":"2019","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.sjopt.2013.06.007","article-title":"Ocular manifestations of graft-versus-host disease","volume":"27","author":"Nassar","year":"2013","journal-title":"Saudi J. Ophthalmol."},{"key":"ref_14","first-page":"111","article-title":"A Significant Role of Stromal Fibroblasts in Rapidly Progressive Dry Eye in Patients with Chronic GVHD","volume":"42","author":"Ogawa","year":"2001","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/archopht.1983.01040010585011","article-title":"The eye in bone marrow transplantation. II. Histopathology","volume":"101","author":"Jabs","year":"1983","journal-title":"Arch. Ophthalmol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.4103\/ijo.IJO_2016_20","article-title":"Update on ocular graft-versus-host disease","volume":"69","author":"Nair","year":"2021","journal-title":"Indian. J. Ophthalmol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/bmt.2009.312","article-title":"Baseline profiles of ocular surface and tear dynamics after allogeneic hematopoietic stem cell transplantation in patients with or without chronic GVHD-related dry eye","volume":"45","author":"Wang","year":"2010","journal-title":"Bone Marrow Transplant."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"108115","DOI":"10.1016\/j.exer.2020.108115","article-title":"Biological functions of tear film","volume":"197","author":"Pflugfelder","year":"2020","journal-title":"Exp. Eye Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/bmt.2015.72","article-title":"Meibography and meibomian gland measurements in ocular graft-versus-host disease","volume":"50","author":"Wittig","year":"2015","journal-title":"Bone Marrow Transplant."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Cheng, X., Huang, R., Huang, S., Fan, W., Yuan, R., Wang, X., and Zhang, X. (2023). Recent advances in ocular graft-versus-host disease. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1092108"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.survophthal.2012.08.004","article-title":"Ocular graft-versus-host disease: A review","volume":"58","author":"Shikari","year":"2013","journal-title":"Surv. Ophthalmol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1007\/s00417-017-3759-x","article-title":"Corneal features in ocular graft-versus-host disease by in vivo confocal microscopy","volume":"255","author":"Tepelus","year":"2017","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1001\/archopht.1989.01070020413046","article-title":"The Eye in Bone Marrow Transplantation: III. Conjunctival Graft-vs-Host Disease","volume":"107","author":"Jabs","year":"1989","journal-title":"Arch. Ophthalmol."},{"key":"ref_24","first-page":"S570","article-title":"Understanding Ocular Graft-versus-Host Disease to Facilitate an Integrated Multidisciplinary Approach","volume":"30","author":"Surico","year":"2024","journal-title":"Transpl. Cell Ther."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1038\/srep03419","article-title":"International Chronic Ocular Graft-vs-Host-Disease (GVHD) Consensus Group: Proposed Diagnostic Criteria for Chronic GVHD (Part I)","volume":"3","author":"Ogawa","year":"2013","journal-title":"Sci. Rep."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Tappeiner, C., Heiligenhaus, A., Halter, J.P., Miserocchi, E., Bandello, F., and Goldblum, D. (2023). Challenges and concepts in the diagnosis and management of ocular graft-versus-host disease. Front. Med., 10.","DOI":"10.3389\/fmed.2023.1133381"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ophtha.2016.11.008","article-title":"Predictors of Discordance between Symptoms and Signs in Dry Eye Disease","volume":"124","author":"Vehof","year":"2017","journal-title":"Ophthalmology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"DES71","DOI":"10.1167\/iovs.17-23750","article-title":"Sj\u00f6gren\u2019s Syndrome, Non-Sj\u00f6gren\u2019s Syndrome, and Graft-Versus-Host Disease Related Dry Eye","volume":"59","author":"Ogawa","year":"2018","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jtos.2024.05.002","article-title":"Delayed diagnosis of ocular graft-versus-host disease after allogeneic hematopoietic stem cell transplantation","volume":"34","author":"Liao","year":"2024","journal-title":"Ocul. Surf."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41433-018-0210-4","article-title":"Comparison among different diagnostic criteria for chronic ocular graft-versus-host disease applied with and without pre-transplant ophthalmological examination","volume":"33","author":"Giannaccare","year":"2019","journal-title":"Eye"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jtos.2017.05.001","article-title":"TFOS DEWS II Diagnostic Methodology report","volume":"15","author":"Wolffsohn","year":"2017","journal-title":"Ocul. Surf."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"153","DOI":"10.5045\/kjh.2011.46.3.153","article-title":"Treatment of chronic graft-versus-host disease: Past, present and future","volume":"46","author":"Martin","year":"2011","journal-title":"Korean J. Hematol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbmt.2010.05.011","article-title":"Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease","volume":"17","author":"Wolff","year":"2011","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/j.bbmt.2019.03.003","article-title":"Changes in Immunosuppressive Treatment of Chronic Graft-versus-Host Disease: Comparison of 2 Surveys within Allogeneic Hematopoietic Stem Cell Transplant Centers in Germany, Austria, and Switzerland","volume":"25","author":"Wolff","year":"2019","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_36","unstructured":"Brott, N.R., Zeppieri, M., and Ronquillo, Y. (2025, August 28). Schirmer Test, StatPearls [Internet], Available online: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK559159\/."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00003226-200305000-00001","article-title":"One-minute schirmer test with anesthesia","volume":"22","author":"Bawazeer","year":"2003","journal-title":"Cornea"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1001\/jama.2013.280318","article-title":"Conjunctivitis: A systematic review of diagnosis and treatment","volume":"310","author":"Azari","year":"2013","journal-title":"JAMA"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jtos.2018.05.002","article-title":"Corneal fluorescein staining and ocular symptoms but not Schirmer test are useful as indicators of response to treatment in chronic ocular GVHD","volume":"16","author":"Amparo","year":"2018","journal-title":"Ocul. Surf."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.4103\/IJO.IJO_2839_22","article-title":"A brief account on ocular graft versus host disease","volume":"71","author":"Chatterjee","year":"2023","journal-title":"Indian J. Ophthalmol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/j.jcrs.0000000000001318","article-title":"Applications of the pinhole effect in clinical vision science","volume":"50","author":"Kanclerz","year":"2024","journal-title":"J. Cataract. Refract. Surg."},{"key":"ref_42","unstructured":"ODBBAL (2025, August 28). A Peek at the Pinhole [Internet]. Available online: https:\/\/www.reviewofoptometry.com\/article\/a-peek-at-the-pinhole."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"15926","DOI":"10.1038\/s41598-022-19990-z","article-title":"A plethora of ocular surface manifestations in a multidisciplinary ocular graft-versus-host disease unit","volume":"12","author":"Trindade","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_44","first-page":"68","article-title":"A study of conjunctival impression cy-tology in patients undergoing allogeneic hematopoietic stem cell transplantation and its relationship with Ocular Graft versus Host Disease","volume":"69","author":"Pradeep","year":"2025","journal-title":"Rom. J. Ophthalmol."},{"key":"ref_45","unstructured":"Ortiz-Perez, S., Zeppieri, M., and Patel, B.C. (2025, October 18). Blepharochalasis Syndrome, StatPearls [Internet], Available online: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK560620\/."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0002-9394(14)73926-1","article-title":"Dermatochalasis and dry eye","volume":"115","author":"Vold","year":"1993","journal-title":"Am. J. Ophthalmol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1080\/08820538.2017.1282970","article-title":"The Histopathological Findings of Patients Who Underwent Blepharoplasty Due to Dermatochalasis","volume":"33","author":"Karnaz","year":"2018","journal-title":"Semin. Ophthalmol."},{"key":"ref_48","unstructured":"Fu, L., and Patel, B.C. (2025, August 28). Lagophthalmos, StatPearls [Internet], Available online: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK560661\/."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0181-5512(04)96192-X","article-title":"Lower lid blepharoplasty","volume":"27","author":"Ritleng","year":"2004","journal-title":"J. Fr. Ophtalmol."},{"key":"ref_50","unstructured":"Labib, A., Patel, B.C., and Milroy, C. (2025, August 29). Lower Eyelid Laxity Examination, StatPearls [Internet], Available online: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK576403\/."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1475-1313.1990.tb00968.x","article-title":"Meibomian gland dysfunction: Some clinical, biochemical and physical observations","volume":"10","author":"Ong","year":"1990","journal-title":"Ophthalmic Physiol. Opt."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s40135-014-0041-9","article-title":"MGD Diagnosis","volume":"2","author":"Arita","year":"2014","journal-title":"Curr. Ophthalmol. Rep."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1167\/iovs.10-6997a","article-title":"The international workshop on meibomian gland dysfunction: Executive summary","volume":"52","author":"Nichols","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1167\/iovs.10-6997c","article-title":"The international workshop on meibomian gland dysfunction: Report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland","volume":"52","author":"Knop","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ajo.2010.04.016","article-title":"Association of dyslipidemia in moderate to severe meibomian gland dysfunction","volume":"150","author":"Dao","year":"2010","journal-title":"Am. J. Ophthalmol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1097\/OPX.0b013e318157ac9e","article-title":"The Development of Validated Bulbar Redness Grading Scales","volume":"84","author":"Schulze","year":"2007","journal-title":"Optom. Vis. Sci."},{"key":"ref_57","unstructured":"Pult, H. (ResearchGate, 2016). Improved meiboscale for meibography, ResearchGate."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1001\/archopht.1994.01090150102031","article-title":"The Eye in Bone Marrow Transplantation: VI. Retinal Complications","volume":"112","author":"Coskuncan","year":"1994","journal-title":"Arch. Ophthalmol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0002-9394(02)01464-2","article-title":"Graft-vs-host-disease-associated conjunctival chemosis and central serous chorioretinopathy after bone marrow transplant","volume":"134","author":"Cheng","year":"2002","journal-title":"Am. J. Ophthalmol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/01.ico.0000240101.66652.36","article-title":"Perforated Corneal Ulcer with Subsequent Endophthalmitis in a Patient with Graft-Versus-Host Disease","volume":"26","author":"Adrean","year":"2007","journal-title":"Cornea"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0002-9394(02)01425-3","article-title":"Scleritis as the initial clinical manifestation of graft-versus-host disease after allogenic bone marrow transplantation","volume":"133","author":"Kim","year":"2002","journal-title":"Am. J. Ophthalmol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1080\/08820538.2022.2075706","article-title":"Lacrimal Gland Insufficiency in Aqueous Deficiency Dry Eye Disease: Recent Advances in Pathogenesis, Diagnosis, and Treatment","volume":"37","author":"Doctor","year":"2022","journal-title":"Semin. Ophthalmol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"436","DOI":"10.5935\/0004-2749.20190097","article-title":"Effectiveness of using preservative-free artificial tears versus preserved lubricants for the treatment of dry eyes: A systematic review","volume":"82","author":"Ribeiro","year":"2019","journal-title":"Arq. Bras. Oftalmol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.jtos.2020.07.018","article-title":"Efficacy and Retention of Silicone Punctal Plugs for Treatment of Dry Eye in Patients with and without Ocular Graft-Versus-Host-Disease","volume":"18","author":"Singh","year":"2020","journal-title":"Ocul. Surf."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jtos.2024.08.006","article-title":"Punctal cautery in dry eye disease: A systematic review","volume":"34","author":"Ranjan","year":"2024","journal-title":"Ocul. Surf."},{"key":"ref_66","first-page":"269","article-title":"Oral pilocarpine for the treatment of dry eye in patients with Sj\u00f6gren\u2019s syndrome","volume":"85","author":"Felberg","year":"2022","journal-title":"Arq. Bras. Oftalmol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1007\/s40265-022-01782-4","article-title":"Varenicline Solution Nasal Spray: A Review in Dry Eye Disease","volume":"82","author":"Frampton","year":"2022","journal-title":"Drugs"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1167\/tvst.9.12.23","article-title":"Novel Extranasal Tear Stimulation: Pivotal Study Results","volume":"9","author":"Ji","year":"2020","journal-title":"Transl. Vis. Sci. Technol."},{"key":"ref_69","unstructured":"Carreno-Galeano, J.T., Johns, L., Yin, J., and Dana, R. (2022). Therapeutic effect of topical autologous serum on ocular graft-versus-host disease associated dry eyes. Investig. Ophthalmol. Vis. Sci., 63."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"19279","DOI":"10.1038\/s41598-023-46671-2","article-title":"Efficacy and safety of platelet-rich plasma and autologous-serum eye drops for dry eye in primary Sj\u00f6gren\u2019s syndrome: A randomized trial","volume":"13","author":"Kang","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.2147\/OPTH.S367807","article-title":"Autologous Platelet-Rich Plasma Drops for Evaporative Dry Eye Disease from Meibomian Gland Dysfunction: A Pilot Study","volume":"16","author":"Murtaza","year":"2022","journal-title":"Clin. Ophthalmol."},{"key":"ref_72","first-page":"63772","article-title":"Platelet-rich plasma lysate for treatment of eye surface diseases","volume":"186","author":"Merolle","year":"2022","journal-title":"J. Vis. Exp. JoVE"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Li, N., Ge, Z., and Li, F. (2024). Blood component therapy for dry eye disease: A systematic review and network meta-analysis. Front. Med., 11.","DOI":"10.3389\/fmed.2024.1500160"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ajo.2018.03.024","article-title":"Reduced Efficacy of Low-dose Topical Steroids in Dry Eye Disease Associated with Graft-versus-host Disease","volume":"190","author":"Yin","year":"2018","journal-title":"Am. J. Ophthalmol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1038\/s41433-024-03311-x","article-title":"Evolving therapeutic paradigms in ocular graft-versus-host disease","volume":"38","author":"Masalkhi","year":"2024","journal-title":"Eye"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2165\/00002018-200225010-00004","article-title":"Locally administered ocular corticosteroids: Benefits and risks","volume":"25","author":"McGhee","year":"2002","journal-title":"Drug Saf."},{"key":"ref_77","first-page":"e66437","article-title":"Effects and Safety of 5% Lifitegrast Ophthalmic Solution in Patients with Dry Eye Disease Associated with Ocular Graft-Versus-Host Disease","volume":"16","author":"Wong","year":"2024","journal-title":"Cureus"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1097\/01.ico.0000208813.17367.0c","article-title":"Efficacy of topical cyclosporine 0.05% in the treatment of dry eye associated with graft versus host disease","volume":"25","author":"Rao","year":"2006","journal-title":"Cornea"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jtos.2014.12.006","article-title":"Efficacy and Safety of Topical 0.05% Cyclosporine Eye Drops in the Treatment of Dry Eye Syndrome: A Systematic Review and Meta-analysis","volume":"13","author":"Wan","year":"2015","journal-title":"Ocul. Surf."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1097\/ICO.0b013e3181e456f0","article-title":"Treatment of ocular graft-versus-host disease with topical cyclosporine 0.05%","volume":"29","author":"Malta","year":"2010","journal-title":"Cornea"},{"key":"ref_81","unstructured":"Mayo Clinic [Internet] (2025, December 17). Cyclosporine (Ophthalmic Route)\u2014Side Effects & Dosage. Available online: https:\/\/www.mayoclinic.org\/drugs-supplements\/cyclosporine-ophthalmic-route\/description\/drg-20063370."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.ophtha.2016.02.044","article-title":"A Clinical Trial Comparing the Safety and Efficacy of Topical Tacrolimus versus Methylprednisolone in Ocular Graft-versus-Host Disease","volume":"123","author":"Abud","year":"2016","journal-title":"Ophthalmology"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1089\/jop.2012.0265","article-title":"Treatment of Refractory Dry Eye Associated with Graft Versus Host Disease with 0.03% Tacrolimus Eyedrops","volume":"29","author":"Udaondo","year":"2013","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/1523-1747.ep12555654","article-title":"Dapsone suppresses integrin-mediated neutrophil adherence function","volume":"98","author":"Booth","year":"1992","journal-title":"J. Investig. Dermatol."},{"key":"ref_85","first-page":"e80958","article-title":"Tolerability and Efficacy of Topical Methotrexate in Ocular Surface Disease","volume":"17","author":"Seto","year":"2025","journal-title":"Cureus"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Luo, Z.K., Domenech-Estarellas, E.A., Han, A., Lee, D., Khatri, R., Wahl, J.L., Cutler, C., Armand, P., Antin, J.H., and Koreth, J. (2021). Efficacy and Safety of 1% Progesterone Gel to the Forehead for Ocular Chronic Graft-versus-Host Disease. Transpl. Cell Ther., 27.","DOI":"10.1016\/j.jtct.2021.02.008"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Radu, A.-F., Bungau, S.G., Aron, R.A.C., Tarce, A.G., Bodog, R., Bodog, T.M., and Radu, A. (2024). Deciphering the Intricate Interplay in the Framework of Antibiotic-Drug Interactions: A Narrative Review. Antibiotics, 13.","DOI":"10.3390\/antibiotics13100938"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00003226-199001000-00011","article-title":"In vitro toxicity of gentamicin to corneal epithelial cells","volume":"9","author":"Alfonso","year":"1990","journal-title":"Cornea"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Wang, D.H., Guo, H., Xu, W., and Liu, X.Q. (2024). Efficacy and safety of the disposable eyelid warming masks in the treatment of dry eye disease due to Meibomian gland dysfunction. BMC Ophthalmol., 24.","DOI":"10.1186\/s12886-024-03642-z"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"5292","DOI":"10.1097\/MS9.0000000000002322","article-title":"MEIBO (perfluorohexyloctane): A novel approach to treating dry eye disease","volume":"86","author":"Azhar","year":"2024","journal-title":"Ann. Med. Surg."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1097\/ICO.0000000000003418","article-title":"Long-Term Safety and Efficacy of Perfluorohexyloctane Ophthalmic Solution for the Treatment of Patients with Dry Eye Disease: The KALAHARI Study","volume":"43","author":"Protzko","year":"2024","journal-title":"Cornea"},{"key":"ref_92","unstructured":"Cleveland Clinic [Internet] (2025, December 17). Erythromycin Eye Ointment. Available online: https:\/\/my.clevelandclinic.org\/health\/drugs\/19501-erythromycin-eye-ointment."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1038\/s41433-020-0876-2","article-title":"Systematic review and meta-analysis of treating meibomian gland dysfunction with azithromycin","volume":"34","author":"Tao","year":"2020","journal-title":"Eye"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/cxo.12557","article-title":"Assessment of efficacy of topical azithromycin 1.5 per cent ophthalmic solution for the treatment of meibomian gland dysfunction","volume":"101","author":"Balci","year":"2018","journal-title":"Clin. Exp. Optom."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.jtos.2024.10.004","article-title":"Mineralocorticoid receptor expression and the effects of the mineralocorticoid receptor antagonist spironolactone in a murine model of graft-versus-host disease","volume":"34","author":"Sato","year":"2024","journal-title":"Ocul. Surf."},{"key":"ref_96","first-page":"e45136","article-title":"Topical Spironolactone in the Treatment of Ocular Graft-Versus-Host Disease","volume":"15","author":"Wong","year":"2023","journal-title":"Cureus"},{"key":"ref_97","first-page":"e41038","article-title":"Topical Spironolactone in the Treatment of Evaporative Dry Eye Disease","volume":"15","author":"Wong","year":"2023","journal-title":"Cureus"},{"key":"ref_98","first-page":"5734","article-title":"Topical Spironolactone Reduces Meibomian Gland Dropout and Corneal Epithelial Changes in Chronic Graft-Versus-Host Disease Mouse Models","volume":"65","author":"Le","year":"2024","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1021\/acs.molpharmaceut.7b01028","article-title":"Topical Administration of Spironolactone-Loaded Nanomicelles Prevents Glucocorticoid-Induced Delayed Corneal Wound Healing in Rabbits","volume":"15","author":"Dahmana","year":"2018","journal-title":"Mol. Pharm."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jtos.2023.10.002","article-title":"Safety and efficacy of intense pulsed light in the treatment of severe chronic ocular graft-versus-host disease","volume":"30","author":"Wang","year":"2023","journal-title":"Ocul. Surf."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/112067210101100215","article-title":"Multilayer amniotic membrane transplantation in severe ocular graft versus host disease","volume":"11","author":"Menezo","year":"2001","journal-title":"Eur. J. Ophthalmol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"476","DOI":"10.4103\/ijo.IJO_2540_20","article-title":"Medical device composed of amniotic membrane inhibits the rapid progression of acute calcareous degeneration caused by ocular graft-versus-host disease: Case report","volume":"1","author":"Wan","year":"2021","journal-title":"Indian. J. Ophthalmol. Case Rep."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.3390\/medicina59101733","article-title":"Corneal Descemetocele Management with Multi-Layer Amniotic Membrane Transplantation in an Ocular Graft-versus-Host Disease Case","volume":"59","author":"He","year":"2023","journal-title":"Medicina"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"25254","DOI":"10.1038\/s41598-024-76249-5","article-title":"Visual and ocular surface benefits of mini-scleral contact lenses in patients with chronic ocular graft-versus-host disease (GvHD)","volume":"14","author":"Keye","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/ICL.0000000000000436","article-title":"Scleral Lenses in the Management of Corneal Irregularity and Ocular Surface Disease","volume":"44","author":"Shorter","year":"2018","journal-title":"Eye Contact Lens"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1136\/bjo.87.10.1279","article-title":"Albumin as a tear supplement in the treatment of severe dry eye","volume":"87","author":"Shimmura","year":"2003","journal-title":"Br. J. Ophthalmol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3747\/co.22.2620","article-title":"Human Albumin Eye Drops as a Therapeutic Option for the Management of Keratoconjunctivitis Sicca Secondary to Chronic Graft-Versus-Host Disease after Stem-Cell Allografting","volume":"22","author":"Seki","year":"2015","journal-title":"Curr. Oncol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s00417-023-06281-0","article-title":"Topical ivermectin ointment treatment of Demodex blepharitis: A 6-year retrospective study","volume":"262","author":"Valvecchia","year":"2024","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"ref_109","first-page":"CD013333","article-title":"Tea tree oil for Demodex blepharitis","volume":"6","author":"Savla","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Ou, S., Cai, M., Feng, Y., Lin, S., Zheng, X., Zhao, S., Gu, H., and Wu, Y. (2025). Ocular surface health and disease: Insight from single-cell RNA sequencing. Front. Genet., 16.","DOI":"10.3389\/fgene.2025.1683167"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ajo.2025.05.033","article-title":"TFOS DEWS III: Diagnostic Methodology","volume":"279","author":"Wolffsohn","year":"2025","journal-title":"Am. J. Ophthalmol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/5\/1926\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T05:12:41Z","timestamp":1772860361000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/5\/1926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,3]]},"references-count":111,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["jcm15051926"],"URL":"https:\/\/doi.org\/10.3390\/jcm15051926","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,3]]}}}